Form 4: Renovaro Inc. Director Ruud Hendriks Acquires Options to Purchase 18,634 Shares
SEC Form 4
Director Ruud Hendriks reports acquiring options to purchase 18,634 shares of Renovaro Inc. common stock at $1.61 per share on June 25, 2024.
Summary
- On June 27, 2024, Ruud Hendriks, a director of Renovaro Inc. (RENB), filed a Form 4 with the SEC.
- The form reports a transaction that occurred on June 25, 2024, where Hendriks acquired options to purchase 18,634 shares of common stock.
- The exercise price of these options is $1.61 per share.
- The options became exercisable immediately on June 25, 2024, and will expire on June 25, 2034.
- Following the reported transaction, Hendriks directly owns 18,634 derivative securities (options).
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting an insider transaction. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
This filing is a routine disclosure of insider transactions, providing transparency to the market regarding the holdings and activities of company directors. It's common for directors to receive stock options as part of their compensation.
Stakeholder Impact
- The acquisition of options by a director could be viewed positively by shareholders as it aligns the director's interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 06/25/2024 | Date of transaction: Ruud Hendriks acquired options to purchase shares of common stock. |
| 06/25/2024 | Options become exercisable. |
| 06/25/2034 | Expiration date of the options. |
| 06/27/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.